News | Hemodynamic Support Devices | September 20, 2018

Abiomed Showcases Expanded FDA Indications, Next-Generation Heart Recovery Products at TCT 2018

Company will feature cath lab experience and demonstrations, presentations on Protected PCI and cardiogenic shock

Abiomed Showcases Expanded FDA Indications, Next-Generation Heart Recovery Products at TCT 2018

September 19, 2018 — Abiomed Inc. announces its initiatives at the 30th Transcatheter Cardiovascular Therapeutics (TCT) conference will highlight the recently expanded U.S. Food and Drug Administration (FDA) indications for high-risk percutaneous coronary intervention (PCI) and cardiogenic shock. Initiatives will also highlight Protected PCI’s ability to allow for more complete revascularization, which improves outcomes1 and quality of life2,3. More than 30 presentations as well as live cases featuring Impella heart pumps are expected at TCT 2018, taking place Sept. 21-25 in San Diego, California.

New for TCT 2018, Abiomed’s booth will feature a cath lab experience with demonstrations and simulations of advancements including:

  • Abiomed’s augmented reality simulator which provides hands-on experience with the Impella RP and the newly FDA approved Impella CP with SmartAssist, which includes hemodynamic sensors to intelligently position and manage the device;
  • Simulations of Impella CP with SmartAssist’s real-time informational displays of new hemodynamic metrics; and
  • Live demonstrations of Abiomed’s latest innovation, Impella Connect, which provides real-time information in the cloud to connect remote support resources.

In the hemodynamic support and patient management pavilion, Abiomed is hosting practical, hands-on workshops on large bore access and closure, advanced hemodynamics, best practices in cardiogenic shock and complex Protected PCI strategies.

Watch the VIDEO Cardiogenic Shock Supported With Impella Shows Good Outcomes

A breakfast symposium on Saturday, Sept. 22 at 6:30 a.m. will feature data on Abiomed’s FDA approval for cardiogenic shock associated with cardiomyopathy, including peripartum and postpartum cardiomyopathy. Faculty will also discuss the role of ventricular unloading and the latest results from the National Cardiogenic Shock Initiative (NCSI). Initial NCSI data showed 76 percent survival and 100 percent native heart recovery when the NCSI protocol and best practices were used.

Watch the VIDEO Overview of the National Cardiogenic Shock Initiative

Protected PCI with Impella allows for more complete revascularization, which improves outcomes and quality of life. Abiomed anticipates the broadcast of several elective high-risk PCI live cases using hemodynamic support with the Impella heart pump.

The schedule for Protected PCI and cardiogenic shock related TCT symposia is included below.

Saturday, Sept. 22

Co-sponsored Symposium:New Treatment Strategies for Cardiogenic Shock: Impella Expanded Indications

6:30–8:00 a.m. | Room 23 B-C

  • Cindy Grines, M.D.: Advances in the Treatment of Cardiovascular Disease in Women: PCI, MI, Shock, Myocarditis, SCAD and Post-partum Cardiomyopathy
  • William O’Neill, M.D.: The Impact of The Cardiogenic Shock Initiative (NCSI): One Year Later
  • Navin Kapur, M.D.: Understanding the Importance of Ventricular Unloading in Management of AMI and Cardiogenic Shock


Presentation Theater Program: Contrast-Induced Acute Kidney Injury – Preventive Measures That Work

Saturday, Sept. 22 | 11:30 a.m.–12:30 p.m.

San Diego Convention Center, Presentation Theater 2, Hall B2, Ground Level

CHIP Angiogram Review: What’s New with Focused Case Presentations

Saturday, Sept. 22 | 6:30–8:00 p.m.

Marriott Marquis San Diego Marina, Pacific Ballroom 18-19

Sunday, Sept. 23

Co-sponsored Symposium: Management of Complex PCI Patients: Award-winning Case Presentations

6:30–8:00 a.m. | Room 23 B-C

Chair: David Wohns, M.D.

Faculty: Amir Kaki, M.D.; George Vetrovec, M.D.

Interactive Training Pavilion: Hemodynamic Support & Patient Management

Saturday, Sept. 22 and Sunday, Sept. 23

  • Large Bore Access & Closure
    • Faculty: Amir Kaki, M.D.; James McCabe, M.D.; Raj Tayal, M.D.
  • Cardiogenic Shock (NCSI)
    • Faculty: Navin Kapur, M.D.; William O’Neill, M.D.; Brian Porvin, M.D.
  • TEACH Intro
    • Faculty: Dan Burkoff, M.D.; Reshad Garan, M.D.; John Lasala, M.D.; Salvatore Mannino, M.D.; Perwaiz Meraj, M.D.; Lynn Morris, M.D.; Raj Patel, M.D.; Brian Porvin, M.D.
  • Complex Protected PCI
    • Faculty: Hiram Bezerra, M.D.; Dan Burkoff, M.D.; Mauricio Cohen, M.D.; Colin Hirst, M.D.; Paul Mahoney, M.D.; Duane Pinto, M.D.; Uma Rangasetty, M.D.; Adhir Shroff, M.D.

For more information:

Related Content

VIDEO: Hemodynamic Support Protocols at Henry Ford Hospital


  1. Dangas, G. et al. Am. Journ of Cardiol. 2014 Jan 15;113(2):222-8.
  2. Abiomed data on file.
  3. O'Neill, W. et al. Circulation. 2012 Oct 2;126(14):1717-27.

Related Content

News | TCT

August 4, 2022 — The Cardiovascular Research Foundation (CRF) has announced the late-breaking clinical science that will ...

Home August 04, 2022
News | TCT

August 2, 2022 — Two significant awards will be presented at TCT 2022, to be held in Boston, Sept. 16-19, 2022. Career ...

Home August 02, 2022
News | TCT

July 12, 2022 — The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that they are ...

Home July 12, 2022
Feature | TCT

November 10, 2021 — There were nine late-breaking trials and 13 late-breaking science presentations at the 2021 ...

Home November 10, 2021
Feature | TCT | Dave Fornell, Editor

Here are some of the key takeaways from the late-breaking interventional cardiology and structural heart trials ...

Home October 29, 2020
Feature | TCT

October 15, 2020 — The late-breaking studies are one of the hallmarks of the annual Transcatheter Cardiovascular ...

Home October 15, 2020
News | TCT

October 14, 2020 — The American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF) are ...

Home October 14, 2020
Videos | TCT

With COVID-19 forcing all medical conferences to go virtual in 2020, Juan F. Granada, M.D., CEO of the Cardiovascular ...

Home August 01, 2020
Feature | TCT | Dave Fornell, Editor

The latest in interventional cardiology clinical data and new device technologies were highlighted at the annual ...

Home November 04, 2019
Feature | TCT

October 10, 2019 — Here are the Cardiovascular Research Foundation (CRF) 12 late-breaking trials and 16 late-breaking ...

Home October 11, 2019
Subscribe Now